Last reviewed · How we verify
anti-Mesothelin Car NK Cells
anti-Mesothelin Car NK Cells is a Biologic drug developed by Allife Medical Science and Technology Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | anti-Mesothelin Car NK Cells |
|---|---|
| Sponsor | Allife Medical Science and Technology Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- anti-Mesothelin Car NK Cells CI brief — competitive landscape report
- anti-Mesothelin Car NK Cells updates RSS · CI watch RSS
- Allife Medical Science and Technology Co., Ltd. portfolio CI
Frequently asked questions about anti-Mesothelin Car NK Cells
What is anti-Mesothelin Car NK Cells?
anti-Mesothelin Car NK Cells is a Biologic drug developed by Allife Medical Science and Technology Co., Ltd..
Who makes anti-Mesothelin Car NK Cells?
anti-Mesothelin Car NK Cells is developed by Allife Medical Science and Technology Co., Ltd. (see full Allife Medical Science and Technology Co., Ltd. pipeline at /company/allife-medical-science-and-technology-co-ltd).
What development phase is anti-Mesothelin Car NK Cells in?
anti-Mesothelin Car NK Cells is in Phase 1.